People
-
Transpire Bio, a start-up inhaled drug developer based in Florida, has announced the appointment of two more OINDP experts, naming William Schachtner as Chief Technical Operations Officer and Axel Perlwitz as Chief Regulatory Affairs Officer.… Read more . . .
-
Inhaled flecanide developer InCarda Therapeutics has named former Arena Pharmaceuticals executive Robert Lisicki as CEO, succeeding Grace Colón who the company says “intends to pursue other leadership opportunities within the life science space” but will continue… Read more . . .
-
Shortly after Savara announced the resignation of Badrul Chowdhury as its Chief Medical Officer, Philip Morris International (PMI) has announced the appointment of Chowdhury as PMI’s new Chief Life Sciences Officer, Smoke-Free Products, effective in… Read more . . .
-
Savara has announced the resignation of Badrul Chowdhury as Chief Medical Officer, effective September 9, 2022. Chowdhury, a former Director of the FDA’s Division of Pulmonary, Allergy, and Rheumatology Products, joined Savara as CMO in November… Read more . . .
-
Verona Pharma, which recently announced that a Phase 3 trial of its nebulized ensifentrine for the treatment of COPD met its primary endpoint, has announced the appointments of Matthew Casbon as VP of Sales, Marketing,… Read more . . .
-
Dry powder nebulizer developer Nob Hill Therapeutics announced the appointment of Noel Greenberger as its new CEO, replacing interim CEO Yun Li as of September 1, and said that it has received a Department of… Read more . . .
-
California-based nebulizer developer Respira Technologies has announced that Chief Operating Officer Brian Quigley will replace company founder Mario Danek as CEO, and Danek will take over the role of Chief Technology Officer. Quigley joined the… Read more . . .
-
OINDP characterization specialist Proveris Scientific announced that former Proveris Associate Product Manager Alyssa Rubino has rejoined the company as a Technical Data Scientist at Proveris Laboratories. Rubino, who was most recently Medical and Dental Product… Read more . . .
-
Intranasal vaccine developer Meissa Vaccines has announced that Martin Moore is stepping down as the company’s CEO and Frank Glavin has joined the company as the new Chief Executive Officer. Moore will stay with Meissa… Read more . . .
-
Hailie inhaler monitoring system maker Adherium has announced the appointment of Tara Creaven-Capasso as VP of Quality, Regulatory and Clinical Affairs. Creaven-Capasso has been a long-time regulatory affairs consultant; earlier in her career, she also… Read more . . .
Featured event:

Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal



